logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage

Part (i) All injecting drug users, 2009 to 2010

 
 

Notes:

Black squares indicate samples with national coverage; blue triangles indicate samples with subnational (including local or regional) coverage.

Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary and some sample sizes are small.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of subnational data.

Source:

Reitox national reports 2011.

Country Hungary Malta Netherlands Czech Republic Slovakia Slovenia Turkey Cyprus Finland Greece United Kingdom Sweden Bulgaria Norway Luxembourg Austria Romania Belgium Latvia Poland Lithuania Italy Portugal Spain
National 0 0   0.6 0.3 0.4 0.5 0 0.7 0.7       2.3972603 2.4 0.7 4.2   6.3 6.8   11.5 4.9 32.3
        0       1.2875536   0.8           5.3             17.2  
        0.2                                     11.9  
                                                 
Subnational 0   0   2 0.4       0 1.1 2 2.2 0.6   0 1.1135857 5.3 2.9 26.4 5 5.9    
  0   0             0.8 0.6         0.8   3.4 6.1 8.8607595 6.7 4.5    
  0   0             0.9 4.3         0   6 19.8   21.4 2.6    
                    0 0         0         18.4 4.2    
                    1.2 0.4                   7.1 2.9    
                    0.9                     0 25.6    
                    0                       3.6    
                    3.6                       11.5    
                    0                       18.5    
                    0                       17.3    
                    0                       5.5    
                    0                       0.9    
                    0                       14.8    
                    0                       7.3    
                    0                       26.4    
                    0                       3.9    
                                            10.7    
                                            10.1    
                                            9.9    
                                            5.3    
                                            11.4    

inffig3a

 

Page last updated: Sunday, 15 July 2012